Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models
Functional precision medicine aims to match individual cancer patients to optimal treatment through ex vivo drug susceptibility testing on patient-derived cells. However, few functional diagnostic assays have been validated against patient outcomes at scale because of limitations of such assays. Her...
| Huvudupphovsmän: | , , , , , , , , , , |
|---|---|
| Övriga upphovsmän: | |
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Elsevier BV
2023
|
| Länkar: | https://hdl.handle.net/1721.1/147876 |